S. Korea approves Phase III trial of SK Bioscience's COVID-19 vaccine
AsiaToday reporters Kim Si-young & Park Ah-ram As various countries are competing to develop COVID-19 vaccines amid the pandemic, South Korea..
Stay updated with breaking news from Isk Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AsiaToday reporters Kim Si-young & Park Ah-ram As various countries are competing to develop COVID-19 vaccines amid the pandemic, South Korea..
MSCI Korea Index's quarterly review includes SK Bioscience, SKIET, EcoProBM
Hasil uji klinis tahap ketiga vaksin COVID-19 buatan Korsel didukung pemerintah.
South Korea gave vaccine developer SK Bioscience the green light on Tuesday for a Phase III study of its COVID-19 vaccine candidate at a time of vaccine shortages, when a spurt in infections is fueling demand.
SK Bioscience's COVID-19 vaccine candidate to enter phase 3 clinical trial